CHD
Neutral signalScored 2026-08-26 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.
Research, not advice.
À propos
Church & Dwight Co., Inc.
- Nom
- Church & Dwight Co., Inc.
- Secteur
- Consumer Defensive
- Industrie
- Household & Personal Products
- Bourse
- NYSE
- Capitalisation
- $25.0B
- Employés
- 5,550
- PDG
- Richard A. Dierker
- Site web
- https://www.churchdwight.com
- Marché
- CLCLXETTYFHENOYKAOCFKMB
Church & Dwight Co., Inc. is a company dedicated to the creation, production, and marketing of a diverse portfolio encompassing household, personal care, and specialized industrial goods. Its operations are structured into three principal divisions: Consumer Domestic, Consumer International, and the Specialty Products Division. The company offers a broad array of well-known consumer brands. Under the ARM & HAMMER umbrella, it provides cat litters, carpet fresheners, laundry detergents, baking soda, and various other baking soda-based items. Sexual health products, including condoms, lubricants, and vibrators, are marketed under the TROJAN brand. OXICLEAN delivers stain removers, cleaning solutions, laundry detergents, and bleach alternatives. SPINBRUSH offers both battery-operated and manual toothbrushes. Home pregnancy and ovulation test kits are available through FIRST RESPONSE. NAIR specializes in depilatories, while ORAJEL provides oral pain relief. XTRA is another prominent laundry detergent brand. Gummy dietary supplements are sold under the L'IL CRITTERS and VITAFUSION labels. BATISTE is known for its dry shampoos. WATERPIK manufactures water flossers and replacement showerheads. The company also includes its FLAWLESS range of products, ZICAM for cold symptom relief, and THERABREATH for oral care. Beyond consumer items, Church & Dwight supplies specialty products. These include advanced animal productivity solutions such as MEGALAC, a rumen bypass fat supplement designed to help cows sustain energy during peak milk production. BIO-CHLOR and FERMENTEN are utilized to mitigate health issues linked to calving and to provide essential protein. CELMANAX is a refined functional carbohydrate and yeast-based prebiotic. Furthermore, the company furnishes sodium bicarbonate for industrial use, as well as various cleaning and deodorizing compounds. Church & Dwight distributes its consumer goods through an extensive network of retail outlets, including supermarkets, large department stores, wholesale clubs, drugstores, convenience stores, home goods stores, dollar and other discount retailers, pet stores, specialized shops, and various online e-commerce channels. Its specialty products, conversely, reach industrial clients and livestock producers via dedicated distributors. Founded in 1846, Church & Dwight Co., Inc. maintains its corporate headquarters in Ewing, New Jersey.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 17 500 titres (~1 798 884,97 $ US)
- Insiders
- IRWIN BRADLEY CWINKLEBLACK ARTHUR B
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$5,462,035
Avg sell (VWAP, 90d window) $102.57 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-11
- Last synced
-
2026-08-21 23:36:53
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-26 | Linares Carlos G. | Sell · S | 15,375 | $103.00 | $1,583,625 | Form 4 |
| 2026-08-25 | Hemsey Rene | Sell · S | 5,000 | $102.25 | $511,275 | Form 4 |
| 2026-08-24 | Linares Carlos G. | Sell · S | 15,375 | $102.00 | $1,568,250 | Form 4 |
| 2026-08-11 | IRWIN BRADLEY C | Sell · S | 4,300 | $102.69 | $441,575 | Form 4 |
| 2026-08-05 | WINKLEBLACK ARTHUR B | Sell · S | 13,200 | $102.83 | $1,357,310 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-10-10 | Richard W. Allen | Sale | $15,001 - $50,000 |
| 2025-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-09-25 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-08-04 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-08-04 | Ro Khanna | Purchase | $1,000 - $15,000 |
| 2025-06-24 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-17 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-05-14 | Jonathan Jackson | Sale | $15,001 - $50,000 |
| 2025-05-05 | Jonathan Jackson | Sale | $1,001 - $15,000 |
| 2025-04-23 | Jonathan Jackson | Purchase | $1,001 - $15,000 |
| 2025-03-24 | Jonathan Jackson | Purchase | $1,001 - $15,000 |
| 2025-03-03 | Jonathan Jackson | Purchase | $1,001 - $15,000 |
| 2024-11-13 | Jonathan Jackson | Purchase | $15,001 - $50,000 |
| 2024-03-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-02-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-11-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-17 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-06-16 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-05-23 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2021-11-18 | Peter Welch | Sale (Full) | $15,001 - $50,000 |
| 2021-03-10 | Richard W. Allen | Sale (Full) | $15,001 - $50,000 |
| 2021-03-10 | Richard W. Allen | Sale (Full) | $15,001 - $50,000 |
| 2021-01-25 | Richard W. Allen | Purchase | $15,001 - $50,000 |
| 2020-02-28 | Peter Welch | Purchase | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-08-26 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.
CHD presents a moderately compelling setup driven by a solid Q2 2026 earnings beat, 5.8% organic sales growth, and raised full-year guidance, supported by improving profitability and cash flow trends.
The first sentence of the analysis written for CHD on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Supports a bullish reading. 7 purchase disclosures year to date
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 1.07 · operating margin 17%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 44.7% | 45.7% | 44.1% | 41.9% | 43.6% | |
| Ebit Margin | 17.0% | 13.9% | 18.4% | 11.4% | 20.9% | |
| Ebitda Margin | 20.9% | 17.9% | 22.2% | 15.5% | 25.1% | |
| Operating Profit Margin | 17.4% | 13.2% | 18.0% | 11.1% | 20.8% | |
| Pretax Profit Margin | 15.4% | 12.4% | 16.5% | 9.7% | 19.9% | |
| Continuous Operations Profit Margin | 11.9% | 9.6% | 12.9% | 7.7% | 15.9% | |
| Net Profit Margin | 11.9% | 9.6% | 12.9% | 7.7% | 15.9% | |
| Bottom Line Profit Margin | 11.9% | 9.6% | 12.9% | 7.7% | 15.9% | |
| Current Ratio | 1.066 | 1.703 | 1.076 | 1.179 | 0.594 | |
| Quick Ratio | 0.709 | 1.237 | 0.644 | 0.633 | 0.336 | |
| Solvency Ratio | 0.200 | 0.182 | 0.208 | 0.130 | 0.220 | |
| Cash Ratio | 0.273 | 0.733 | 0.242 | 0.228 | 0.116 | |
| Price To Earnings Ratio | 27.582 | 43.812 | 30.602 | 47.418 | 30.325 | |
| Price To Earnings Growth Ratio | 1.014 | -1.934 | 0.374 | -0.954 | 4.822 | |
| Forward Price To Earnings Growth Ratio | 1.014 | -1.934 | 0.374 | -0.954 | 4.822 | |
| Price To Earnings Diluted Ratio | 27.765 | 44.181 | 31.003 | 47.982 | 30.873 | |
| Price To Earnings Diluted Growth Ratio | 1.012 | -1.982 | 0.380 | -0.971 | 4.816 | |
| Price To Book Ratio | 5.085 | 5.928 | 6.007 | 5.611 | 7.764 | |
| Price To Sales Ratio | 3.281 | 4.233 | 3.947 | 3.642 | 4.837 | |
| Price To Free Cash Flow Ratio | 18.619 | 26.478 | 28.693 | 27.718 | 28.688 | |
| Price To Operating Cash Flow Ratio | 16.744 | 22.360 | 22.470 | 22.119 | 25.259 | |
| Debt To Assets Ratio | 0.247 | 0.271 | 0.304 | 0.341 | 0.342 | |
| Debt To Equity Ratio | 0.551 | 0.552 | 0.676 | 0.816 | 0.846 | |
| Debt To Capital Ratio | 0.355 | 0.356 | 0.403 | 0.449 | 0.458 | |
| Long Term Debt To Capital Ratio | 0.355 | 0.336 | 0.364 | 0.427 | 0.333 | |
| Financial Leverage Ratio | 2.227 | 2.037 | 2.223 | 2.391 | 2.473 | |
| Working Capital Turnover Ratio | 12.116 | 11.831 | 36.697 | -17.074 | -9.285 | |
| Operating Cash Flow Ratio | 0.812 | 0.879 | 0.725 | 0.748 | 0.479 | |
| Operating Cash Flow Sales Ratio | 0.196 | 0.189 | 0.176 | 0.165 | 0.191 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.899 | 0.844 | 0.783 | 0.798 | 0.880 | |
| Debt Service Coverage Ratio | 11.338 | 7.217 | 3.217 | 3.895 | 1.068 | |
| Interest Coverage Ratio | 11.319 | 8.496 | 9.535 | 6.672 | 19.800 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 35.685 | 4.510 | 9.230 | 1.018 | |
| Operating Cash Flow Coverage Ratio | 0.551 | 0.481 | 0.396 | 0.311 | 0.364 | |
| Capital Expenditure Coverage Ratio | 9.930 | 6.430 | 4.611 | 4.951 | 8.365 | |
| Dividend Paid And Capex Coverage Ratio | 2.967 | 2.531 | 2.103 | 2.041 | 2.713 | |
| Dividend Payout Ratio | 0.390 | 0.473 | 0.353 | 0.616 | 0.299 | |
| Enterprise Value Multiple | 17.042 | 25.031 | 19.500 | 26.634 | 21.141 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 44.7% | ▼-0.9% | ▲0.7% |
| Ebit Margin | 17.0% | ▲3.0% | ▲0.6% |
| Ebitda Margin | 20.9% | ▲3.1% | ▲0.6% |
| Operating Profit Margin | 17.4% | ▲4.2% | ▲1.3% |
| Pretax Profit Margin | 15.4% | ▲3.0% | ▲0.6% |
| Continuous Operations Profit Margin | 11.9% | ▲2.3% | ▲0.3% |
| Net Profit Margin | 11.9% | ▲2.3% | ▲0.3% |
| Bottom Line Profit Margin | 11.9% | ▲2.3% | ▲0.3% |
| Current Ratio | 1.066 | ▼-0.636 | ▼-0.057 |
| Quick Ratio | 0.709 | ▼-0.527 | ▼-0.003 |
| Solvency Ratio | 0.200 | ▲0.018 | ▲0.012 |
| Cash Ratio | 0.273 | ▼-0.460 | ▼-0.045 |
| Price To Earnings Ratio | 27.582 | ▼-16.230 | ▼-8.366 |
| Price To Earnings Growth Ratio | 1.014 | ▲2.948 | ▲0.350 |
| Forward Price To Earnings Growth Ratio | 1.014 | ▲2.948 | ▲0.350 |
| Price To Earnings Diluted Ratio | 27.765 | ▼-16.416 | ▼-8.596 |
| Price To Earnings Diluted Growth Ratio | 1.012 | ▲2.994 | ▲0.361 |
| Price To Book Ratio | 5.085 | ▼-0.844 | ▼-0.994 |
| Price To Sales Ratio | 3.281 | ▼-0.953 | ▼-0.707 |
| Price To Free Cash Flow Ratio | 18.619 | ▼-7.859 | ▼-7.420 |
| Price To Operating Cash Flow Ratio | 16.744 | ▼-5.616 | ▼-5.047 |
| Debt To Assets Ratio | 0.247 | ▼-0.023 | ▼-0.054 |
| Debt To Equity Ratio | 0.551 | ▼-0.001 | ▼-0.137 |
| Debt To Capital Ratio | 0.355 | ▼-0.000 | ▼-0.049 |
| Long Term Debt To Capital Ratio | 0.355 | ▲0.019 | ▼-0.008 |
| Financial Leverage Ratio | 2.227 | ▲0.190 | ▼-0.043 |
| Working Capital Turnover Ratio | 12.116 | ▲0.285 | ▲5.258 |
| Operating Cash Flow Ratio | 0.811 | ▼-0.067 | ▲0.083 |
| Operating Cash Flow Sales Ratio | 0.196 | ▲0.007 | ▲0.013 |
| Free Cash Flow Operating Cash Flow Ratio | 0.899 | ▲0.055 | ▲0.058 |
| Debt Service Coverage Ratio | 11.338 | ▲4.122 | ▲5.991 |
| Interest Coverage Ratio | 11.319 | ▲2.824 | ▲0.155 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-35.685 | ▼-10.089 |
| Operating Cash Flow Coverage Ratio | 0.551 | ▲0.070 | ▲0.131 |
| Capital Expenditure Coverage Ratio | 9.930 | ▲3.499 | ▲3.072 |
| Dividend Paid And Capex Coverage Ratio | 2.967 | ▲0.436 | ▲0.496 |
| Dividend Payout Ratio | 0.390 | ▼-0.084 | ▼-0.036 |
| Enterprise Value Multiple | 17.042 | ▼-7.989 | ▼-4.828 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $20.35B | $25.85B | $23.16B | $19.58B | $25.10B | |
| Enterprise value | $22.15B | $27.29B | $25.42B | $22.16B | $27.60B | |
| EV / Sales | 3.57x | 4.47x | 4.33x | 4.12x | 5.32x | |
| EV / Op. cash flow | 18.22x | 23.61x | 24.66x | 25.03x | 27.77x | |
| EV / Free cash flow | 20.26x | 27.95x | 31.49x | 31.37x | 31.54x | |
| EV / EBITDA | 17.04x | 25.03x | 19.50x | 26.63x | 21.14x | |
| Net debt / EBITDA | 1.38x | 1.32x | 1.74x | 3.10x | 1.91x | |
| Current ratio | 1.07x | 1.70x | 1.08x | 1.18x | 0.59x | |
| Income quality | 1.65x | 1.98x | 1.36x | 2.14x | 1.20x | |
| Graham number | $34 | $31 | $33 | $23 | $32 | |
| Graham net-net | -$16 | -$11 | -$15 | -$16 | -$16 | |
| Tax burden | 77.0% | 77.4% | 78.1% | 79.1% | 80.2% | |
| Interest burden | 91.0% | 88.8% | 89.7% | 85.4% | 95.0% | |
| Working capital | $99.3M | $924.7M | $107.7M | $212.1M | -$841.8M | |
| Invested capital | $7.06B | $7.18B | $6.77B | $6.83B | $5.58B | |
| Return on assets | 8.3% | 6.6% | 8.8% | 5.0% | 10.3% | |
| Operating ROA | 12.1% | 9.2% | 12.5% | 7.3% | 14.0% | |
| Return on tangible assets | 26.6% | 16.4% | 26.6% | 16.6% | 37.1% | |
| Return on equity | 18.4% | 13.4% | 19.6% | 11.9% | 25.6% | |
| Return on invested capital | 11.2% | 8.2% | 11.2% | 6.5% | 12.5% | |
| Return on capital employed | 14.5% | 10.7% | 14.8% | 8.3% | 18.2% | |
| Earnings yield | 3.6% | 2.3% | 3.3% | 2.1% | 3.3% | |
| Free cash flow yield | 5.4% | 3.8% | 3.5% | 3.6% | 3.5% | |
| Capex / Op. cash flow | 10.1% | 15.6% | 21.7% | 20.2% | 12.0% | |
| Capex / Depreciation | 49.5% | 75.2% | 113.4% | 81.6% | 54.2% | |
| Capex / Sales | 2.0% | 2.9% | 3.8% | 3.3% | 2.3% | |
| SG&A / Sales | 27.4% | 26.6% | 26.1% | 23.1% | 22.8% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.9% | 1.0% | 1.1% | 0.6% | 0.5% | |
| Intangibles / Total assets | 68.9% | 59.9% | 66.9% | 70.2% | 72.1% | |
| Days sales outstanding | 35d | 36d | 33d | 29d | 29d | |
| Days payables outstanding | 78d | 78d | 70d | 78d | 83d | |
| Operating cycle | 92d | 103d | 101d | 104d | 95d | |
| Cash conversion cycle | 14d | 26d | 31d | 26d | 13d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-16 Church & Dwight: Volume-Driven Growth And Margin Recovery Support A Buy Church & Dwight is rated Buy, supported by robust volume-led organic growth, market share gains, and consistent guidance outperformance. CHD''s strategy of acquiring and scaling underpenetrated, high-margin brands like TheraBreath and Hero underpins a multi-year growth runway. Gross margin expansion and operating leverage are expected to accelerate as comps ease, with margin improvement likely in H2 and into 2027.
- 2026-08-12 4 Consumer Staples Stocks to Watch Amid Ongoing Industry Pressures Despite cost pressures and spending volatility, CL, KMB, CHD and BJ are using strategic initiatives and operational efficiencies to drive growth.
- 2026-08-07 Church & Dwight (NYSE:CHD) & Reynolds Consumer Products (NASDAQ:REYN) Head-To-Head Review Reynolds Consumer Products (NASDAQ: REYN - Get Free Report) and Church and Dwight (NYSE: CHD - Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations. Valuation and Earnings This table
- 2026-07-31 Church & Dwight Co., Inc. (CHD) Q2 2026 Earnings Call Transcript Church & Dwight Co., Inc. (CHD) Q2 2026 Earnings Call Transcript
- 2026-07-31 Church & Dwight Co Inc (CHD) (Q2 2026) Earnings Call Highlights: Organic Sales Surge 5.8% and Full-Year Outlook Raised Net Sales Growth: Reported net sales increased 1.6% in Q2, ahead of company outlook.Organic Sales Growth: Organic sales grew 5.8%, well above the 3% outlook, dr
- 2026-07-31 Church & Dwight Q2 Earnings Call Highlights Church & Dwight NYSE: CHD reported second-quarter results that exceeded its prior outlook, driven by broad-based volume growth, market-share gains and contributions from innovation. The company raised its full-year sales, earnings and cash-flow outlook despite what management described as a dynamic operating environment marked by inflation, tariffs and transportation costs.
- 2026-07-31 CHD Q2 Earnings Match Estimates, Sales Beat on Strong Organic Growth Church & Dwight''s Q2 sales beat as organic growth reaches 5.8%, prompting higher 2026 sales, earnings and cash flow forecasts.
- 2026-07-31 Compared to Estimates, Church & Dwight (CHD) Q2 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Church & Dwight (CHD) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 2026-07-31 Church & Dwight (CHD) Meets Q2 Earnings Estimates Church & Dwight (CHD) came out with quarterly earnings of $0.89 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.94 per share a year ago.
- 2026-07-31 Church & Dwight Lifts Outlook After 2Q Organic Sales Jump The consumer goods company behind brands including Arm & Hammer and Trojan said it now expects sales to be flat to up 1% for the full year, instead of down 0.5% to 1.5%.